Ian Michael Estepan - Net Worth and Insider Trading
Ian Michael Estepan Net Worth
The estimated net worth of Ian Michael Estepan is at least $4 Million dollars as of 2024-11-05. Ian Michael Estepan is the CFO of Sarepta Therapeutics Inc and owns about 33,946 shares of Sarepta Therapeutics Inc (SRPT) stock worth over $4 Million. Details can be seen in Ian Michael Estepan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ian Michael Estepan has not made any transactions after 2024-08-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ian Michael Estepan
Ian Michael Estepan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ian Michael Estepan owns 1 companies in total, including Sarepta Therapeutics Inc (SRPT) .
Click here to see the complete history of Ian Michael Estepan’s form 4 insider trades.
Insider Ownership Summary of Ian Michael Estepan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SRPT | Sarepta Therapeutics Inc | 2024-08-30 | Chief Financial Officer |
Ian Michael Estepan Latest Holdings Summary
Ian Michael Estepan currently owns a total of 1 stock. Ian Michael Estepan owns 33,946 shares of Sarepta Therapeutics Inc (SRPT) as of August 30, 2024, with a value of $4 Million.
Latest Holdings of Ian Michael Estepan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SRPT | Sarepta Therapeutics Inc | 2024-08-30 | 33,946 | 125.01 | 4,243,589 |
Holding Weightings of Ian Michael Estepan
Ian Michael Estepan Form 4 Trading Tracker
According to the SEC Form 4 filings, Ian Michael Estepan has made a total of 2 transactions in Sarepta Therapeutics Inc (SRPT) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Sarepta Therapeutics Inc is the sale of 5,985 shares on August 30, 2024, which brought Ian Michael Estepan around $822,100.
Insider Trading History of Ian Michael Estepan
- 1
Ian Michael Estepan Trading Performance
Ian Michael Estepan Ownership Network
Ownership Network List of Ian Michael Estepan
Ownership Network Relation of Ian Michael Estepan
Ian Michael Estepan Owned Company Details
What does Sarepta Therapeutics Inc do?
Who are the key executives at Sarepta Therapeutics Inc?
Ian Michael Estepan is the Chief Financial Officer of Sarepta Therapeutics Inc. Other key executives at Sarepta Therapeutics Inc include Chief Tech Ops Officer Bilal Arif , SVP & General Counsel Ryan Edward Brown , and director & President & CEO Douglas S Ingram .
Sarepta Therapeutics Inc (SRPT) Insider Trades Summary
Over the past 18 months, Ian Michael Estepan made 2 insider transaction in Sarepta Therapeutics Inc (SRPT) with a net sale of 7,185. Other recent insider transactions involving Sarepta Therapeutics Inc (SRPT) include a net purchase of 105,570 shares made by Michael Andrew Chambers , a net sale of 40,957 shares made by Ryan Edward Brown , and a net sale of 30,000 shares made by Wigzell Hans Lennart Rudolf .
In summary, during the past 3 months, insiders sold 5,985 shares of Sarepta Therapeutics Inc (SRPT) in total and bought 37,038 shares, with a net purchase of 31,053 shares. During the past 18 months, 99,430 shares of Sarepta Therapeutics Inc (SRPT) were sold and 180,795 shares were bought by its insiders, resulting in a net purchase of 81,365 shares.
Sarepta Therapeutics Inc (SRPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sarepta Therapeutics Inc Insider Transactions
Ian Michael Estepan Mailing Address
Above is the net worth, insider trading, and ownership report for Ian Michael Estepan. You might contact Ian Michael Estepan via mailing address: 215 First Street, Ste 415, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
